The store will not work correctly when cookies are disabled.
6-(fluoro(pyrimidin-5-yl)methyl)-N-(4-methylthiazol-2-yl)quinoline-8-carboxamide
ID: ALA4202502
Chembl Id: CHEMBL4202502
PubChem CID: 118400861
Max Phase: Preclinical
Molecular Formula: C19H14FN5OS
Molecular Weight: 379.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1csc(NC(=O)c2cc(C(F)c3cncnc3)cc3cccnc23)n1
Standard InChI: InChI=1S/C19H14FN5OS/c1-11-9-27-19(24-11)25-18(26)15-6-13(5-12-3-2-4-23-17(12)15)16(20)14-7-21-10-22-8-14/h2-10,16H,1H3,(H,24,25,26)
Standard InChI Key: WGFRPZSHAGYGHR-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.42 | Molecular Weight (Monoisotopic): 379.0903 | AlogP: 4.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.65 | CX Basic pKa: 2.87 | CX LogP: 2.68 | CX LogD: 2.68 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.58 | Np Likeness Score: -1.96 |
References
1. Felts AS, Rodriguez AL, Morrison RD, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA.. (2018) Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5., 28 (10): [PMID:29705142] [10.1016/j.bmcl.2018.04.053] |